4.7 C
New York
Wednesday, December 6, 2023

Is Fresenius Medical Care AG & Co. KGaA ADR (NYSE: FMS) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Fresenius Medical Care AG & Co. KGaA ADR (FMS) shows that investor sentiment remained same, with the stock’s consolidated last price to $19.40. The Fresenius Medical Care AG & Co. KGaA ADR has recorded 8,961 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter.

Stocks Info

FMS belongs to the Healthcare sector of the NYSE while operating in the Medical Care Facilities industry. At the end of the last regular session, the stock closed at $19.40 and fluctuated between $19.48 as its day high and $18.82 as its day low. The current market capitalization of Fresenius Medical Care AG & Co. KGaA ADR is $11.38B. A total of 1.25 million shares were traded on the day, compared to an average of 540.80K shares.

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, FMS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 1 BUYs and 0 SELLs from insiders. Insiders purchased 3,295 shares during that period but sold 0.


Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Fresenius Medical Care AG & Co. KGaA ADR pays an annual dividend of $0.51, resulting in a dividend yield of 2.61%, and it has a price to earnings (P/E) ratio of 18.40. FMS’s most recent ex-dividend date was 5/17/2023 when it declared a $0.7086 quarterly dividend that was paid in cash on 6/1/2023. Previously, the company paid the dividend on 5/27/2022 with an ex-dividend date of 5/13/2022. The FMS stock dividend was $0.7093 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for FMS in the last 3 months, the mean price target is $21.58 with high estimates of $28.67 and low estimates of $12.74. In terms of 52-week highs and lows, FMS has a high of $27.72 and a low of $14.82.

As of this writing, FMS has an earnings estimate of $0.34 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $0.34 per share and a lower estimate of $0.34. The company reported an EPS of $0.31 in the last quarter, which was 3.30% higher than expectations of $0.3.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. FMS’s latest balance sheet shows that the firm has $1.62B in Cash & Short Term Investments as of fiscal 2021. There were $13.32B in debt and $7.26B in liabilities at the time. Its Book Value Per Share was $25.27, while its Total Shareholder’s Equity was $13.98B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FMS is Buy with a score of 3.13.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles